Cargando…
Evaluation of chromosome 17 polysomy in breast cancer by FISH analysis of whole nuclei, and its clinicopathological significance
Human epidermal growth factor receptor 2 (HER2) amplification and overexpression are associated with poor prognosis and resistance to cytotoxic drugs in patients with breast cancer. Increases in the number of HER2 gene copies have been shown to be associated with chromosome 17 polysomy. The use of w...
Autores principales: | JIANG, HUIYONG, BAI, XIAOYAN, MENG, FANJUN, ZHANG, CHENG, ZHANG, XUEFENG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049721/ https://www.ncbi.nlm.nih.gov/pubmed/24932267 http://dx.doi.org/10.3892/ol.2014.2001 |
Ejemplares similares
-
Angiomatous meningiomas have a distinct genetic profile with multiple chromosomal polysomies including polysomy of chromosome 5
por: Abedalthagafi, Malak S., et al.
Publicado: (2014) -
HER2, chromosome 17 polysomy and DNA ploidy status in breast cancer; a translational study
por: Halilovic, Altuna, et al.
Publicado: (2019) -
Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma
por: Deenonpoe, Raksawan, et al.
Publicado: (2022) -
Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization
por: Jiang, Huiyong, et al.
Publicado: (2012) -
Analysis of ALK gene in 133 patients with breast cancer revealed polysomy of chromosome 2 and no ALK amplification
por: Hanna, Matthew G., et al.
Publicado: (2015)